1. Aaberg TM Jr, Flynn HW Jr, Schiffman J, Newton J. Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. Ophthalmology. 1998; 105:1004–10.
2. Eifrig CW, Flynn HW Jr, Scott IU, Newton J. Acute-onset postoperative endophthalmitis: review of incidence and visual outcomes (1995-2001). Ophthalmic Surg Lasers. 2002; 33:373–8.
Article
3. Kattan HM, Flynn HW Jr, Pflugfelder SC, et al. Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology. 1991; 98:227–38.
4. Wu PC, Kuo HK, Li M, et al. Nosocomial postoperative endophthalmitis: a 14-year review. Graefes Arch Clin Exp Ophthalmol. 2006; 244:920–9.
Article
5. Price FW Jr, Wellemeyer M. Long-term results of Molteno implants. Ophthalmic Surg. 1995; 26:130–5.
Article
6. Nguyen QH, Budenz DL, Parrish RK 2nd. Complications of Baerveldt glaucoma drainage implants. Arch Ophthalmol. 1998; 116:571–5.
Article
7. Djodeyre MR, Peralta Calvo J, Abelairas Gomez J. Clinical evaluation and risk factors of time to failure of Ahmed Glaucoma Valve implant in pediatric patients. Ophthalmology. 2001; 108:614–20.
8. Morad Y, Donaldson CE, Kim YM, et al. The Ahmed drainage implant in the treatment of pediatric glaucoma. Am J Ophthalmol. 2003; 135:821–9.
Article
9. Johnson MW, Doft BH, Kelsey SF, et al. The Endophthalmitis Vitrectomy Study. Relationship between clinical presentation and microbiologic spectrum. Ophthalmology. 1997; 104:261–72.
10. Busbee BG, Recchia FM, Kaiser R, et al. Bleb-associated endophthalmitis: clinical characteristics and visual outcomes. Ophthalmology. 2004; 111:1495–503. discussion 1503.
11. Higginbotham EJ, Stevens RK, Musch DC, et al. Bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology. 1996; 103:650–6.
Article
12. Greenfield DS, Suñer IJ, Miller MP, et al. Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol. 1996; 114:943–9.
Article
13. Uhm KB, Kim TW, Kim JH, Hong C. Risk Factors for the Development of Thin-walled Blebs after Mitomycin C Trabeculectomy. J Korean Ophthalmol Soc. 1996; 37:1032–44.
14. Parrish R, Minckler D. “Late endophthalmitis”. –filtering surgery time bomb? Ophthalmology. 1996; 103:1167–8.
15. Mandelbaum S, Forster RK. Endophthalmitis associated with filtering blebs. Int Ophthalmol Clin. 1987; 27:107–11.
Article
16. Al-Torbak AA, Al-Shahwan S, Al-Jadaan I, et al. Endophthalmitis associated with the Ahmed glaucoma valve implant. Br J Ophthalmol. 2005; 89:454–8.
Article
17. Francis BA, DiLoreto DA Jr, Chong LP, Rao N. Late-onset bacteria endophthalmitis following glaucoma drainage implantation. Ophthalmic Surg Lasers Imaging. 2003; 34:128–30.
18. Kil YG, Jin SM, Chung DY. A case of late onset bleb-related endophthalmitis after trabeculectomy with mitomycin C. J Korean Ophthalmol Soc. 1999; 40:2036–42.
19. Cha SC, Lee KW, Hahn DK. Late onset endophthalmitis following filtering surgery. J Korean Ophthalmol Soc. 1988; 29:195–9.
20. Kim JH, Sohn YH, Uhm KB, Hong C. Two cases of bleb-related endophthalmitis after trabeculectomy with mitomycin C. J Korean Ophthalmol Soc. 1997; 38:336–42.
21. Jampel HD, Quigley HA, Kerrigan-Baumrind LA, et al. Risk factors for late-onset infection following glaucoma filtration surgery. Arch Ophthalmol. 2001; 119:1001–8.
Article
22. Mochizuki K, Jikihara S, Ando Y, et al. Incidence of delayed onset infection after trabeculectomy with adjunctive mitomycin C or 5-fluorouracil treatment. Br J Ophthalmol. 1997; 81:877–83.
Article
23. Song A, Scott IU, Flynn HW Jr, Budenz DL. Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology. 2002; 109:985–91.
24. Fanous MM, Cohn RA. Propionibacterium endophthalmitis following Molteno tube repositioning. J Glaucoma. 1997; 6:201–2.
Article
25. Chen PP, Palmberg PF. Needling revision of glaucoma drainage device filtering blebs. Ophthalmology. 1997; 104:1004–10.
Article
26. Beck AD, Wilson WR, Lynch MG, et al. Trabeculectomy with adjunctive mitomycin C in pediatric glaucoma. Am J Ophthalmol. 1998; 126:648–57.
Article
27. Sidoti PA, Belmonte SJ, Liebmann JM, Ritch R. Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas. Ophthalmology. 2000; 107:422–9.
28. Gedde SJ, Scott IU, Tabandeh H, et al. Late endophthalmitis associated with glaucoma drainage implants. Ophthalmology. 2001; 108:1323–7.
Article
29. Perkins TW. Endophthalmitis after placement of a Molteno implant. Ophthalmic Surg. 1990; 21:733–4.
Article
30. Ellis BD, Varley GA, Kalenak JW, et al. Bacterial endophthalmitis following cataract surgery in an eye with a preexisting Molteno implant. Ophthalmic Surg. 1993; 24:117–8.
Article
31. Mather R, Karenchak LM, Romanowski EG, Kowalski RP. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol. 2002; 133:463–6.
32. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol. 1995; 113:1479–96.
33. Tsai JC, Johnson CC, Kammer JA, Dietrich MS. The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma II: longer-term outcomes from a single surgeon. Ophthalmology. 2006; 113:913–7.
34. Woodcock MG, Richards JC, Murray AD. The last 11 years of Molteno implantation at the University of Cape Town. Refining our indications and surgical technique. Eye (Lond). 2008; 22:18–25.
Article
35. Lehmann OJ, Bunce C, Matheson MM, et al. Risk factors for development of post-trabeculectomy endophthalmitis. Br J Ophthalmol. 2000; 84:1349–53.
Article